ProFibrix expands management team
This article was originally published in Scrip
Executive Summary
ProFibrix, a Dutch biotech company focused on products to stop bleeding and initiate tissue repair, has appointed Dr Jan Ohrstrom chief operating officer and to its executive management team. He will be based in Seattle, US, where ProFibrix has established a wholly owned subsidiary – ProFibrix Inc. Dr Ohrstrom was previously part of the senior management team that took ZymoGenetics public.
You may also be interested in...
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.